HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jonathan Z Li Selected Research
Jonathan Z Li Research Topics
Disease
64
COVID-19
05/2024 - 10/2020
25
Viremia
02/2024 - 09/2012
15
Infections
01/2024 - 09/2014
10
Acquired Immunodeficiency Syndrome (AIDS)
02/2024 - 04/2005
8
Inflammation (Inflammations)
02/2024 - 01/2015
6
HIV Infections (HIV Infection)
02/2024 - 11/2015
4
Neoplasms (Cancer)
03/2024 - 01/2017
3
Virus Diseases (Viral Diseases)
04/2024 - 09/2023
3
Human Influenza (Influenza)
02/2024 - 12/2020
3
Hematologic Neoplasms (Hematological Malignancy)
01/2024 - 01/2017
2
Disease Progression
05/2024 - 04/2011
2
Critical Illness (Critically Ill)
02/2024 - 10/2021
2
Weight Loss (Weight Reduction)
01/2023 - 01/2023
2
Breakthrough Infections
10/2022 - 03/2022
2
Pneumonia (Pneumonitis)
01/2021 - 09/2007
1
Surgical Wound Infection
03/2024
1
Ventral Hernia
03/2024
1
Maternal Obesity
02/2024
1
Fetal Death
02/2024
1
Respiratory Insufficiency (Respiratory Failure)
09/2023
1
Hypoxia (Hypoxemia)
09/2023
1
Vomiting
01/2023
1
Nausea
01/2023
1
COVID-19 breakthrough infections
01/2023
1
Gastroesophageal Reflux (GERD)
01/2023
1
Chronic Disease (Chronic Diseases)
01/2023
1
Postoperative Nausea and Vomiting (PONV)
01/2023
1
Post-Acute COVID-19 Syndrome
01/2023
1
Atherosclerosis
12/2022
1
Cardiovascular Diseases (Cardiovascular Disease)
12/2022
1
Urinary Retention
01/2022
1
Postoperative Pain
01/2022
1
Inguinal Hernia (Direct Inguinal Hernia)
01/2022
Drug/Important Bio-Agent (IBA)
23
RNA (Ribonucleic Acid)
IBA
10/2023 - 04/2011
14
Monoclonal Antibodies
IBA
05/2024 - 12/2021
14
Antiviral Agents (Antivirals)
IBA
05/2024 - 01/2021
9
DNA (Deoxyribonucleic Acid)
IBA
02/2024 - 12/2012
8
Antibodies
IBA
10/2023 - 11/2020
6
Cytokines
IBA
02/2024 - 01/2021
6
bamlanivimab
IBA
01/2023 - 09/2021
5
Interferons
IBA
02/2024 - 11/2014
5
Viral RNA
IBA
01/2024 - 01/2021
5
nirmatrelvir and ritonavir drug combination
IBA
11/2023 - 08/2022
5
Vaccines
IBA
01/2023 - 04/2011
5
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2021
4
Neutralizing Antibodies
IBA
10/2022 - 11/2020
4
Nucleic Acids
IBA
12/2021 - 09/2020
3
Antigens
IBA
10/2023 - 12/2021
3
Interleukin-10 (Interleukin 10)
IBA
12/2022 - 03/2021
3
N-(2-cyanoethylene)urea (BA 1)
IBA
10/2022 - 01/2022
2
amubarvimab
IBA
05/2024 - 01/2023
2
romlusevimab
IBA
05/2024 - 01/2023
2
Immunologic Factors (Immunomodulators)
IBA
02/2024 - 01/2021
2
Immunoglobulin G (IgG)
IBA
10/2023 - 01/2023
2
Immunoglobulins (Immunoglobulin)
IBA
10/2023 - 01/2023
2
Amphiregulin
IBA
11/2022 - 01/2021
2
N-methyl-valyl-amiclenomycin (BA 2)
IBA
10/2022 - 03/2022
2
Fluspirilene (Imap)
IBA
01/2022 - 01/2021
2
Serine Proteases (Serine Protease)
IBA
12/2021 - 12/2020
2
Angiotensin-Converting Enzyme 2
IBA
12/2021 - 12/2020
2
Proteins (Proteins, Gene)
FDA Link
10/2021 - 11/2020
2
Fc Receptors (Fc Receptor)
IBA
10/2021 - 03/2021
2
Interferon Lambda
IBA
03/2021 - 01/2021
2
Furin
IBA
02/2021 - 01/2021
2
Transcription Factors (Transcription Factor)
IBA
01/2021 - 12/2020
1
Prostaglandins A
IBA
03/2024
1
cemiplimab
IBA
03/2024
1
Interleukin-27 (Interleukin 27)
IBA
02/2024
1
crexavibart
IBA
01/2024
1
ogalvibart
IBA
01/2024
1
Immunoglobulin A (IgA)
IBA
10/2023
1
Immunoglobulin M (IgM)
IBA
10/2023
1
camostat
IBA
10/2023
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
09/2023
1
Acids
IBA
01/2023
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2023
1
cilgavimab
IBA
01/2023
1
tixagevimab
IBA
01/2023
1
Peptides (Polypeptides)
IBA
01/2023
1
SAB-185
IBA
01/2023
1
Viral Antigens
IBA
01/2023
1
Interleukin-7 (Interleukin 7)
IBA
01/2023
1
Calcium
IBA
12/2022
1
Granzymes (Granzyme)
IBA
01/2022
1
Narcotics (Narcotic Analgesics)
IBA
01/2022
1
COVID-19 Vaccines
IBA
01/2022
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2022
Therapy/Procedure
23
Therapeutics
04/2024 - 09/2012
15
Art Therapy
02/2024 - 01/2014
3
Artificial Respiration (Mechanical Ventilation)
02/2021 - 01/2021
2
Length of Stay
03/2024 - 01/2023
2
Aftercare (After-Treatment)
02/2024 - 01/2023
2
Highly Active Antiretroviral Therapy (HAART)
03/2023 - 02/2011
2
Withholding Treatment
01/2023 - 01/2020
2
Bariatric Surgery
01/2023 - 01/2023
2
Duration of Therapy
12/2022 - 09/2014
1
Intravenous Administration
01/2024
1
Gastrectomy
01/2023
1
Investigational Therapies (Experimental Therapy)
11/2022
1
Urinary Catheters
01/2022